# Humana Inc: financial statements, quarterly

HUM · NYSE · CIK 49071 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hum.md) · [Financials](/companies/hum/financials.md) · [Filings](/companies/hum/filings.md) · [Insiders](/companies/hum/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hum/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [26.7](/filings/0000049071-24-000040.md) | [26.4](/filings/0000049071-24-000055.md) | [26.5 d](/filings/0000049071-26-000009.md) | [29.6](/filings/0000049071-25-000023.md) | [29.5](/filings/0000049071-25-000042.md) | [29.4](/filings/0000049071-25-000057.md) | [29.2 d](/filings/0000049071-26-000009.md) | [32.1](/filings/0000049071-26-000023.md) | [32.4](/filings/0000049071-25-000042.md) | [32.6](/filings/0000049071-25-000057.md) | [32.5 d](/filings/0000049071-26-000009.md) | [39.6](/filings/0000049071-26-000023.md) |
| Selling, general and administrative | $bn | [3.1](/filings/0000049071-24-000040.md) | [3.3](/filings/0000049071-24-000055.md) | [3.8 d](/filings/0000049071-26-000009.md) | [3.0](/filings/0000049071-25-000023.md) | [3.1](/filings/0000049071-25-000042.md) | [3.3](/filings/0000049071-25-000057.md) | [4.2 d](/filings/0000049071-26-000009.md) | [3.4](/filings/0000049071-26-000023.md) | [3.5](/filings/0000049071-25-000042.md) | [4.1](/filings/0000049071-25-000057.md) | [4.4 d](/filings/0000049071-26-000009.md) | [4.0](/filings/0000049071-26-000023.md) |
| Operating income | $bn | [1.4](/filings/0000049071-24-000040.md) | [1.2](/filings/0000049071-24-000055.md) | [(0.3) d](/filings/0000049071-26-000009.md) | [1.2](/filings/0000049071-25-000023.md) | [1.1](/filings/0000049071-25-000042.md) | [0.7](/filings/0000049071-25-000057.md) | [(0.5) d](/filings/0000049071-26-000009.md) | [2.0](/filings/0000049071-26-000023.md) | [1.1](/filings/0000049071-25-000042.md) | [0.4](/filings/0000049071-25-000057.md) | [(0.8) d](/filings/0000049071-26-000009.md) | [1.8](/filings/0000049071-26-000023.md) |
| Interest expense | $bn | [0.1](/filings/0000049071-23-000049.md) | [0.1](/filings/0000049071-23-000064.md) | [0.1 d](/filings/0000049071-24-000012.md) | [0.2](/filings/0000049071-24-000023.md) | [0.2](/filings/0000049071-25-000042.md) | [0.2](/filings/0000049071-25-000057.md) | [0.2 d](/filings/0000049071-26-000009.md) | [0.2](/filings/0000049071-26-000023.md) | [0.2](/filings/0000049071-25-000042.md) | [0.2](/filings/0000049071-25-000057.md) | [0.1 d](/filings/0000049071-26-000009.md) | [0.2](/filings/0000049071-26-000023.md) |
| Income tax | $bn | [0.3](/filings/0000049071-24-000040.md) | [0.3](/filings/0000049071-24-000055.md) | [(0.1) d](/filings/0000049071-26-000009.md) | [0.3](/filings/0000049071-25-000023.md) | [0.2](/filings/0000049071-25-000042.md) | [0.2](/filings/0000049071-25-000057.md) | [(0.2) d](/filings/0000049071-26-000009.md) | [0.4](/filings/0000049071-26-000023.md) | [0.2](/filings/0000049071-25-000042.md) | [(0.1)](/filings/0000049071-25-000057.md) | [(0.2) d](/filings/0000049071-26-000009.md) | [0.4](/filings/0000049071-26-000023.md) |
| Net income | $bn | [1.0](/filings/0000049071-24-000040.md) | [0.8](/filings/0000049071-24-000055.md) | [(0.5) d](/filings/0000049071-26-000009.md) | [0.7](/filings/0000049071-25-000023.md) | [0.7](/filings/0000049071-25-000042.md) | [0.5](/filings/0000049071-25-000057.md) | [(0.7) d](/filings/0000049071-26-000009.md) | [1.2](/filings/0000049071-26-000023.md) | [0.5](/filings/0000049071-25-000042.md) | [0.2](/filings/0000049071-25-000057.md) | [(0.8) d](/filings/0000049071-26-000009.md) | [1.2](/filings/0000049071-26-000023.md) |
| Diluted EPS | $ per share | [7.66](/filings/0000049071-24-000040.md) | [6.71](/filings/0000049071-24-000055.md) | not reported | [6.11](/filings/0000049071-25-000023.md) | [5.62](/filings/0000049071-25-000042.md) | [3.98](/filings/0000049071-25-000057.md) | not reported | [10.30](/filings/0000049071-26-000023.md) | [4.51](/filings/0000049071-25-000042.md) | [1.62](/filings/0000049071-25-000057.md) | not reported | [9.83](/filings/0000049071-26-000023.md) |
| Basic EPS | $ per share | [7.70](/filings/0000049071-24-000040.md) | [6.74](/filings/0000049071-24-000055.md) | not reported | [6.13](/filings/0000049071-25-000023.md) | [5.63](/filings/0000049071-25-000042.md) | [3.99](/filings/0000049071-25-000057.md) | not reported | [10.31](/filings/0000049071-26-000023.md) | [4.52](/filings/0000049071-25-000042.md) | [1.62](/filings/0000049071-25-000057.md) | not reported | [9.85](/filings/0000049071-26-000023.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [16.2](/filings/0000049071-23-000049.md) | [15.1](/filings/0000049071-23-000064.md) | [4.7](/filings/0000049071-25-000007.md) | [5.9](/filings/0000049071-24-000023.md) | [5.5](/filings/0000049071-24-000040.md) | [5.1](/filings/0000049071-24-000055.md) | [2.2](/filings/0000049071-26-000009.md) | [4.3](/filings/0000049071-25-000023.md) | [4.0](/filings/0000049071-25-000042.md) | [5.4](/filings/0000049071-25-000057.md) | [4.2](/filings/0000049071-26-000023.md) | [5.0](/filings/0000049071-26-000023.md) |
| Current assets | $bn | [38.8](/filings/0000049071-23-000049.md) | [38.3](/filings/0000049071-23-000064.md) | [30.0](/filings/0000049071-25-000007.md) | [32.8](/filings/0000049071-24-000023.md) | [32.9](/filings/0000049071-24-000040.md) | [32.9](/filings/0000049071-24-000055.md) | [29.8](/filings/0000049071-26-000009.md) | [34.4](/filings/0000049071-25-000023.md) | [33.6](/filings/0000049071-25-000042.md) | [32.8](/filings/0000049071-25-000057.md) | [32.7](/filings/0000049071-26-000023.md) | [38.1](/filings/0000049071-26-000023.md) |
| Total assets | $bn | [56.5](/filings/0000049071-23-000049.md) | [55.9](/filings/0000049071-23-000064.md) | [47.1](/filings/0000049071-25-000007.md) | [50.1](/filings/0000049071-24-000023.md) | [50.1](/filings/0000049071-24-000040.md) | [50.0](/filings/0000049071-24-000055.md) | [46.5](/filings/0000049071-26-000009.md) | [50.9](/filings/0000049071-25-000023.md) | [50.4](/filings/0000049071-25-000042.md) | [49.7](/filings/0000049071-25-000057.md) | [48.9](/filings/0000049071-26-000023.md) | [55.3](/filings/0000049071-26-000023.md) |
| Current liabilities | $bn | [28.3](/filings/0000049071-23-000049.md) | [27.8](/filings/0000049071-23-000064.md) | [18.9](/filings/0000049071-25-000007.md) | [19.7](/filings/0000049071-24-000023.md) | [19.8](/filings/0000049071-24-000040.md) | [18.7](/filings/0000049071-24-000055.md) | [16.9](/filings/0000049071-26-000009.md) | [18.0](/filings/0000049071-25-000023.md) | [17.2](/filings/0000049071-25-000042.md) | [16.2](/filings/0000049071-25-000057.md) | [16.3](/filings/0000049071-26-000023.md) | [21.5](/filings/0000049071-26-000023.md) |
| Total liabilities | $bn | [39.6](/filings/0000049071-23-000049.md) | [38.9](/filings/0000049071-23-000064.md) | [30.7](/filings/0000049071-25-000007.md) | [33.9](/filings/0000049071-24-000023.md) | [33.4](/filings/0000049071-24-000040.md) | [32.4](/filings/0000049071-24-000055.md) | [30.0](/filings/0000049071-26-000009.md) | [33.1](/filings/0000049071-25-000023.md) | [32.1](/filings/0000049071-25-000042.md) | [31.1](/filings/0000049071-25-000057.md) | [31.2](/filings/0000049071-26-000023.md) | [36.6](/filings/0000049071-26-000023.md) |
| Long-term debt | $bn | [9.7](/filings/0000049071-23-000049.md) | [9.5](/filings/0000049071-23-000064.md) | [10.2](/filings/0000049071-25-000007.md) | [12.4](/filings/0000049071-24-000023.md) | [11.7](/filings/0000049071-24-000040.md) | [11.9](/filings/0000049071-24-000055.md) | [11.1](/filings/0000049071-26-000009.md) | [12.7](/filings/0000049071-25-000023.md) | [12.6](/filings/0000049071-25-000042.md) | [12.6](/filings/0000049071-25-000057.md) | [12.4](/filings/0000049071-26-000023.md) | [12.3](/filings/0000049071-26-000023.md) |
| Current portion of debt | $bn | [2.0](/filings/0000049071-23-000049.md) | [2.2](/filings/0000049071-23-000064.md) | [1.4](/filings/0000049071-25-000007.md) | [0.8](/filings/0000049071-24-000023.md) | [1.1](/filings/0000049071-24-000040.md) | [1.1](/filings/0000049071-24-000055.md) | [0.6](/filings/0000049071-26-000009.md) | [0.6](/filings/0000049071-25-000023.md) | [0.0](/filings/0000049071-25-000042.md) | [0.0](/filings/0000049071-25-000057.md) | [0.0](/filings/0000049071-26-000023.md) | [1.7](/filings/0000049071-26-000023.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [16.8](/filings/0000049071-23-000049.md) | [16.9](/filings/0000049071-23-000064.md) | [16.3](/filings/0000049071-25-000007.md) | [16.1](/filings/0000049071-24-000023.md) | [16.7](/filings/0000049071-24-000040.md) | [17.6](/filings/0000049071-24-000055.md) | [16.4](/filings/0000049071-26-000009.md) | [17.8](/filings/0000049071-25-000023.md) | [18.2](/filings/0000049071-25-000042.md) | [18.5](/filings/0000049071-25-000057.md) | [17.7](/filings/0000049071-26-000023.md) | [18.6](/filings/0000049071-26-000023.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3,176 d](/filings/0000049071-24-000040.md) | [1,252 d](/filings/0000049071-24-000055.md) | [(7,134) d](/filings/0000049071-26-000009.md) | [423](/filings/0000049071-25-000023.md) | [1,213 d](/filings/0000049071-25-000042.md) | [1,858 d](/filings/0000049071-25-000057.md) | [(528) d](/filings/0000049071-26-000009.md) | [331](/filings/0000049071-26-000023.md) | [1,271 d](/filings/0000049071-25-000042.md) | [971 d](/filings/0000049071-25-000057.md) | [(1,652) d](/filings/0000049071-26-000009.md) | [1,254](/filings/0000049071-26-000023.md) |
| Capital expenditure | $m | [264 d](/filings/0000049071-24-000040.md) | [234 d](/filings/0000049071-24-000055.md) | [283 d](/filings/0000049071-26-000009.md) | [177](/filings/0000049071-25-000023.md) | [114 d](/filings/0000049071-25-000042.md) | [130 d](/filings/0000049071-25-000057.md) | [154 d](/filings/0000049071-26-000009.md) | [95.0](/filings/0000049071-26-000023.md) | [114 d](/filings/0000049071-25-000042.md) | [135 d](/filings/0000049071-25-000057.md) | [202 d](/filings/0000049071-26-000009.md) | [121](/filings/0000049071-26-000023.md) |
| Dividends paid | $m | [111 d](/filings/0000049071-24-000040.md) | [109 d](/filings/0000049071-24-000055.md) | [111 d](/filings/0000049071-26-000009.md) | [109](/filings/0000049071-25-000023.md) | [107 d](/filings/0000049071-25-000042.md) | [107 d](/filings/0000049071-25-000057.md) | [108 d](/filings/0000049071-26-000009.md) | [108](/filings/0000049071-26-000023.md) | [106 d](/filings/0000049071-25-000042.md) | [107 d](/filings/0000049071-25-000057.md) | [109 d](/filings/0000049071-26-000009.md) | [107](/filings/0000049071-26-000023.md) |
| Share repurchases | $m | [529 d](/filings/0000049071-24-000040.md) | [379 d](/filings/0000049071-24-000055.md) | [571 d](/filings/0000049071-26-000009.md) | [717](/filings/0000049071-25-000023.md) | [49.0 d](/filings/0000049071-25-000042.md) | [2.0 d](/filings/0000049071-25-000057.md) | [49.0 d](/filings/0000049071-26-000009.md) | [9.0](/filings/0000049071-26-000023.md) | [100 d](/filings/0000049071-25-000042.md) | [0.0 d](/filings/0000049071-25-000057.md) | [42.0 d](/filings/0000049071-26-000009.md) | [107](/filings/0000049071-26-000023.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [127](/filings/0000049071-23-000049.md) | [127](/filings/0000049071-23-000064.md) | [126](/filings/0000049071-24-000023.md) | [125](/filings/0000049071-24-000040.md) | [124](/filings/0000049071-24-000055.md) | [121](/filings/0000049071-25-000023.md) | [121](/filings/0000049071-25-000042.md) | [121](/filings/0000049071-25-000057.md) | [121](/filings/0000049071-26-000023.md) | [121](/filings/0000049071-25-000042.md) | [121](/filings/0000049071-25-000057.md) | [121](/filings/0000049071-26-000023.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 120,061,500 at 2026-03-31, from the cover of the [10-Q filed 2026-04-29](/filings/0000049071-26-000023.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.